Learn / RGC
NASDAQ: RGC
Regencell Bioscience Holdings Ltd (RGC) stock, explained like you're 5
Regencell Bioscience Holdings Ltd trades on the Nasdaq under the ticker RGC. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 3.6 billion dollars.
- Ticker
- RGC
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medicinal Chemicals and Botanical Products
- Size
- Mid cap, about 3.6 billion dollars
Is Regencell Bioscience Holdings Ltd a small, medium or large cap company?
No. Regencell Bioscience Holdings Ltd is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Regencell Bioscience Holdings Ltd makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RGC stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- How Investors Are Reacting To Regencell Bioscience Holdings (RGC) Wider Full Year Loss (Yahoo Finance)
- RGC Resources senior VP Lawrence Oliver buys $200 in stock (Investing.com)
- How Investors Are Reacting To Regencell Bioscience Holdings Stock (RGC) Wider Annual Loss (Simply Wall Street)
- Regencell Bioscience RGC Stock and Hims Attempt Bullish Breakout as Healthcare Stocks Revive (FXLeaders)
- RGC Resources (NASDAQ:RGCO) Stock Rating Raised to Hold at Wall Street Zen (MarketBeat)
Follow RGC in your daily brief
Each trading day at 5 PM ET we post what happened to Regencell Bioscience Holdings Ltd and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RGC
Questions about Regencell Bioscience Holdings Ltd stock
What does Regencell Bioscience Holdings Ltd do?
Regencell Bioscience Holdings Ltd trades on the Nasdaq under the ticker RGC. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 3.6 billion dollars.
What is the ticker symbol for Regencell Bioscience Holdings Ltd?
Regencell Bioscience Holdings Ltd trades under the ticker RGC on the Nasdaq.
What is Regencell Bioscience Holdings Ltd's market cap?
Regencell Bioscience Holdings Ltd is a mid cap stock with a market cap of about 3.6 billion dollars.
How does Regencell Bioscience Holdings Ltd make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RGC stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RGC stock every day?
Add RGC to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.